The effect of caffeic acid on the antinociception and mechanisms in mouse

Banskota AH, Tezuka Y, and Kadota S (2001) Recent progression pharmacological research of propolis. Phytother Res 15, 561–571. Bose JS, Gangan V, Jain SK, and Manna SK (2009) Downregulation of inflammatory responses by novel caffeic acid ester derivative by inhibiting NF-kappa B. J Clin Immunol 29, 90–98. Cervero F and Laird JMA (1999) Visceral pain. Lancet 353, 2145–2148. Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, and Suh HW (2003) Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci 471–485. Choi SS, Lee JK, and Suh HW (2001) Antinociceptive profiles of aspirin and acetaminophen in formalin, Substance P and glutamate pain models. Brain Res Bull 7, 233–239. Chung KM, Lee KC, Choi SS, and Suh HW (2001) Differential roles of spinal cholera toxin- and pertussis toxin sensitive G proteins in nociceptive responses caused by formalin, capsaicin and substance P in mice. Brain Res Bull 54, 537–542. Cumberbatch MJ, Herrero JH, and Headley PM (1994) Exposure of rat spinal neurons to NMDA, AMPA and kainate produces only short-term enhancements of responses to noxious and non-noxious stimuli. Neurosci Lett 181, 98–102. Hunskaar S and Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30, 103–114. Hunskaar S, Fasmer OB, and Hole K (1985) Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 14, 69–76. Hylden JL and Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67, 313–316. Hylden JL and Wilcox GL (1981) Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res 217, 212–215. Jensen TS and Yaksh TL (1984) Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res 321, 287–297. Jung JE, Kim HS, Lee CS, Park DH, Kim YN, Lee MJ, Lee JW, Park JW, Kim MS, Ye SK, and Chung MH (2007) Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells. Carcinogenesis 28, 1780–1787. Koster R, Anderson M, and Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18, 412. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, and Dannenberg AJ (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59, 2347–2352. Miles EA, Zoubouli P, Calder PC, and Phil D (2005) Differential anti-inflammatory effects of phenolic compounds from extra virgin olive identified in human whole blood cultures. Nutrition 21, 389–394. Nardini M, Pisu P, Gentili V, Natella F, Di Felice M, Piccolella E, and Scaccini C (1998) Effect of caffeic acid on tert-butyl hydroperoxide-induced oxidative stress in U937. Free Radic Biol Med 25, 1098–1105. Nardini M, Scaccini C, Packer L, and Virgili F (2000). In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim Biophys Acta 1474, 219–225. Pari L and Rasath A (2008) Efficacy of caffeic acid in preventing nickel induced oxidative damage in liver of rats. Chem Biol Interact 173, 77–83. Park SH, Sim YB, Choi SM, Seo YJ, Kwon MS, Lee JK, and Suh HW (2009) Antinociceptive profiles and mechanisms of orally administered vanillin in the mice. Arch Pharm Res 32, 1643–1649. Puig S and Sorkin LS (1989) Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64, 345–355. Satyanarayana PSV, Jain NK, Singh A, and Kulkarni SK (2004) Isobolographic analysis of interaction between cyclooxigenase inhibitors and tramadol in acetic acidinduced writhing in mice. Prog Neuro-Psychopharmacol 28, 641–649. Schmauss C and Yaksh TL (1984) In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 228, 1–12. Sondheimer E (1958) On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch Biochem Biophys 74, 131–138. Suh HW, Chung KM, Kim YH, Huh SO, and Song DK (1999) Effect of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse. Neuropeptides 33, 121–129. Suh HW, Song DK, and Kim YH (1997) Differential effects of adenosine receptor antagonist injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse. Neuropeptides 31, 339–344. Suh HW, Song DK, Son KH, Wie MB, Lee KH, Jung KY, Do JC, and Kim YH (1996) Antinociceptive mechanisms of dipsacus saponin C administered intracerebroventricularly in the mouse. Gen Pharmacology 27, 1167–1172. Ulugol A, Ozyigit F, Yesilyurt O, and Dogrul A (2006) The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac. Anesth Analg 102, 443–447. Vyklicky L (1979) The techniques for the study of pain in animals. In Advances In Pain Research And Theraphy, Bonica JJ, Liebeskind JC, and Albe-Fessard DG (eds.), 3, pp. 727–745, Raven, New York, NY, USA. Wigdor S and Wilcox GL (1987) Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther 242, 90–95. Yaksh TL (1979) Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinpciceptive effects of morphine in the periaqueductal gray. Brain Res 160, 180–185. Yaksh TL (1984) Multiple opioid receptor systems in brain and spinal cord: Part I. Eur J Anaesth 1, 171–199.